General Information of the Compound
| Compound ID |
CP0419240
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[5-cyano-1-[(E)-4-[2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxy-5-(1H-1,2,4-triazol-5-yl)benzimidazol-1-yl]but-2-enyl]-7-(3-morpholin-4-ylpropoxy)benzimidazol-2-yl]-2-ethyl-5-methylpyrazole-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C43H49N15O5
|
||||||||||||||||||
| Molecular Weight |
855.965
|
||||||||||||||||||
| Canonical SMILES |
CCn1nc(C)cc1C(=O)\N=c1/[nH]c2cc(cc(OC)c2n1C\C=C\Cn1c2c(OCCCN3CCOCC3)cc(cc2[nH]\c1=N/C(=O)c1cc(C)nn1CC)C#N)-c1ncn[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C43H49N15O5/c1-6-57-33(19-27(3)52-57)40(59)49-42-47-31-21-29(25-44)22-36(63-16-10-11-54-14-17-62-18-15-54)38(31)56(42)13-9-8-12-55-37-32(23-30(24-35(37)61-5)39-45-26-46-51-39)48-43(55)50-41(60)34-20-28(4)53-58(34)7-2/h8-9,19-24,26H,6-7,10-18H2,1-5H3,(H,45,46,51)(H,47,49,59)(H,48,50,60)/b9-8+
Show/Hide
|
||||||||||||||||||
| InChIKey |
FXHSGPIYRODXAH-CMDGGOBGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03644, Stimulator of interferon genes protein
Protein ID: PT05006, Stimulator of interferon genes protein